Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017 (CROSBI ID 261908)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Plachouras, Diamantis ; Kärki, Tommi ; Hansen, Sonja ; Hopkins, Susan ; Lyytikäinen, Outi ; Moro, Maria Luisa ; Reilly, Jacqui ; Zarb, Peter ; Zingg, Walter ; Kinross, Pete ; Weist, Klaus ; Monnet, Dominique L. ; Suetens, Carl
Point Prevalence Survey Study Group
engleski
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017
Antimicrobial agents used to treat infections are life-saving. Overuse may result in more frequent adverse effects and emergence of multidrug- resistant microorganisms. In 2016-17, we performed the second point-prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in European acute care hospitals. We included 1, 209 hospitals and 310, 755 patients in 28 of 31 European Union/European Economic Area (EU/EEA) countries. The weighted prevalence of antimicrobial use in the EU/EEA was 30.5% (95% CI: 29.2-31.9%). The most common indication for prescribing antimicrobials was treatment of a community- acquired infection, followed by treatment of HAI and surgical prophylaxis. Over half (54.2%) of antimicrobials for surgical prophylaxis were prescribed for more than 1 day. The most common infections treated by antimicrobials were respiratory tract infections and the most commonly prescribed antimicrobial agents were penicillins with beta-lactamase inhibitors. There was wide variation of patients on antimicrobials, in the selection of antimicrobial agents and in antimicrobial stewardship resources and activities across the participating countries. The results of the PPS provide detailed information on antimicrobial use in European acute care hospitals, enable comparisons between countries and hospitals, and highlight key areas for national and European action that will support efforts towards prudent use of antimicrobials.
antibiotic use ; antimicrobial use ; healthcare-associated infections ; hospitals ; point-prevalence surve
Members of the Point Prevalence Survey Study Group: Budimir, Ana (University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia) ; Bošnjak, Zrinka (University of Zagreb School of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia);
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
23 (46)
2018.
1800393
14
objavljeno
1025-496X
1560-7917
10.2807/1560-7917.es.23.46.1800393
Povezanost rada
Kliničke medicinske znanosti